PEAK6 Investments L.P. lifted its holdings in China Cord Blood Corp (NYSE:CO) by 119.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 385,679 shares of the medical research company’s stock after purchasing an additional 210,022 shares during the period. PEAK6 Investments L.P. owned 0.32% of China Cord Blood worth $3,838,000 as of its most recent filing with the SEC.
Several other institutional investors have also bought and sold shares of CO. Renaissance Technologies LLC grew its position in China Cord Blood by 19.9% during the fourth quarter. Renaissance Technologies LLC now owns 1,926,500 shares of the medical research company’s stock worth $19,169,000 after buying an additional 320,200 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its position in China Cord Blood by 81.5% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 599,431 shares of the medical research company’s stock worth $5,964,000 after buying an additional 269,125 shares in the last quarter. Ameriprise Financial Inc. acquired a new stake in China Cord Blood during the third quarter worth about $3,881,000. SG Americas Securities LLC grew its position in China Cord Blood by 131.2% during the third quarter. SG Americas Securities LLC now owns 231,204 shares of the medical research company’s stock worth $2,571,000 after buying an additional 131,204 shares in the last quarter. Finally, First Trust Advisors LP acquired a new stake in China Cord Blood during the fourth quarter worth about $2,265,000. Institutional investors and hedge funds own 21.95% of the company’s stock.
Shares of China Cord Blood Corp (NYSE:CO) opened at $11.15 on Wednesday. China Cord Blood Corp has a 1 year low of $5.06 and a 1 year high of $14.95. The firm has a market capitalization of $1,317.00, a PE ratio of 32.12 and a beta of 0.88.
China Cord Blood Profile
China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee.
Want to see what other hedge funds are holding CO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for China Cord Blood Corp (NYSE:CO).
Receive News & Ratings for China Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.